European Journal of Cancer,

More rationale for optimal sequencing of therapeutic monoclonal antibodies in metastatic colorectal cancer

Publication date: August 2019Source: European Journal of Cancer, Volume 117Author(s): Gerard Milano

European Journal of Cancer

Thu Jul 04, 2019 18:48

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ <em>i</em>LOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Publication date: August 2019Source: European Journal of Cancer, Volume 117Author(s): C. Soussain, S. Choquet, M. Blonski, D. Leclercq, C. Houillier, K. Rezai, F. Bijou, R. Houot, E. Boyle, R. Gressin, E. Nicolas-Virelizier, M. Barrie, C. Moluçon-Chabrot, M.L. Lelez, A. Clavert, S. Coisy, S. Leruez, V. Touitou, N. Cassoux, M. DaniauAbstractBackgroundPrimary central nervous system lymphomas (PCNSLs) are mainly diffuse large B-cell lymphomas (DLBCLs) of the non-germinal centre B-cell subtype, with...

European Journal of Cancer

Thu Jul 04, 2019 18:48

Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy

Publication date: August 2019Source: European Journal of Cancer, Volume 117Author(s): Chee Khoon Lee, Rebecca Asher, Michael Friedlander, Val Gebski, Antonio Gonzalez-Martin, Alain Lortholary, Anne Lesoin, Christian Kurzeder, Remy Largillier, Felix Hilpert, Anne-Claire Hardy-Bessard, Marie-Christine Kaminsky, Andres Poveda, Eric Pujade-LauraineAbstractBackgroundPlatinum-resistant ovarian cancer (PROC) is associated with a variable prognosis and unpredictable survival times. We have developed and...

European Journal of Cancer

Thu Jul 04, 2019 18:48

Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series

Publication date: August 2019Source: European Journal of Cancer, Volume 117Author(s): Juliette Lemasson, Stefania Cuzzubbo, Ludovic Doucet, Valérie Gounant, Barouyr Baroudjian, Florian Herms, Antoine F. Carpentier, Céleste Lebbé, Hélène Vitaux, Charlotte Hautefort, Julie Delyon, PATIO group

European Journal of Cancer

Thu Jul 04, 2019 18:48

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

Publication date: August 2019Source: European Journal of Cancer, Volume 117Author(s): Zong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, Kuan-Yu Chen, Jin-Yuan Shih, Jin-Shing Chen, Zhong-Zhe Lin, Chia-Chi Lin, James Chih-Hsin Yang, Chong-Jen YuAbstractBackgroundReactivation of hepatitis B virus (HBV) is a documented risk during cytotoxic chemotherapy in patients with lung cancer. Cases of HBV reactivation in non–small-cell lung cancer (NSCLC) patients receiving epidermal growth factor receptor (EGFR) tyrosine...

European Journal of Cancer

Thu Jul 04, 2019 18:48

In response to Ham et al.: Antibiotics effect on outcome in head and neck cancer

Publication date: August 2019Source: European Journal of Cancer, Volume 117Author(s): Denaro Nerina, Merlano Marco Carlo

European Journal of Cancer

Thu Jul 04, 2019 18:48